MENOHOP 90 CAPS NF 7717

45.17

Pas en stock. En réapprovisionnement.

FacebookTwitterGoogle Plus

Description

1 capsule per dag of zoals aanbevolen

  • Gluten-vrij
  • Lactose-vrij

1 capsule per dag of zoals aanbevolen

  1. Cos, P.; De Bruyne, T.; Apers, S.; Berghe, D. V.; Pieters, L.; Vlietinck, A. J. Phytoestrogens: Recent developments. Planta Medica 2003, 69, 589-599.

  2. Huntley AL, Ernst E. A systematic review of herbal medicinal products for
    the treatment of menopausal symptoms. Menopause. 2003 Sep-Oct;10(5):465-76.

  3. Milligan SR, Kalita JC, Heyerick A, Rong H, De Cooman L, De Keukeleire D.
    Identification of a potent fytoestrogen in hops (Humulus lupulus L.) and
    beer. J Clin Endocrinol Metab 1999; 84: 2249-2252.

  4. Milligan SR, Kalita JC, Pocock V, et al. The endocrine activities of 8-
    prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J Clin
    Endocrinol Metab 2000; 85: 4912-4915

  5. Chadwick, L.R.; Pauli, G.F.; Farnsworth, N.R.; The Pharmacognosy of
    Humulus lupulus L. (hops) with the emphasis on estrogenic properties.
    Phytomedicine 2006 Jan;13(1-2):119-31.

  6. Huntley AL, Ernst E. Soy for the treatment of perimenopausal symptoms–a
    systematic review. Maturitas. 2004 Jan 20;47(1):1-9.

  7. Goetz, P. Traitement des bouffées de chaleur par insuffisance ovarienne par
    l’extrait de houblon (Humulus lupulus). Revue de Phytothérapie Pratique 1990,
    4, 13-15.

  8. Heyerick, A.; Vervarcke, S.; Depypere, H.; Bracke, M.; De Keukeleire, D. A
    first prospective, randomized, double-blind, placebo-controlled study on the
    use of a standardized hop extract to alleviate menopausal discomforts.
    Maturitas, 2005 Nov 28.

  9. Erkkola R, Vervarcke S, Vansteelandt S, Rompotti P, De Keukeleire D, Heyerick
    A. A randomized, double-blind, placebo-controlled, cross-over pilot study on
    the use of a standardized hop extract to alleviate menopausal discomforts.
    Phytomedicine. 2010 May;17(6):389-96.

  10. Hemachandra et al., Cancer Prev .(Phila), 2011 Oct 13 College of Pharmacy,
    University of Illinois at Chicago, Chicago, USA

Niet gebruiken bij zwangerschap en voorgeschiedenis van hormoonafhankelijkekankers.

INGREDIENTEN PER CAPSULE
Hopextract (Humulus lupulus) gestandaardiseerd op hopeïne 200 mg
8-prenylnaringenine 200 µg
Soja-extract (Glycine max) gestandaardiseerd op isoflavonen 50 mg
soja-isoflavonen 20 mg
Hulpstoffen: dicalciumfosfaat, gelatine, magnesiumstearaat, siliciumdioxide,
kleurstof capsule: ijzeroxiden

Informations complémentaires

Marque